OLLI heads into tomorrow's print as a stock where a meaningful short position sits comfortably alongside loose borrow conditions — a setup worth unpacking before the numbers land.
Short sellers hold a genuinely significant stake in Ollie's: 10.8% of the free float is currently short, up roughly 8% over the past month as the stock recovered 15% from its lows. That month-long build in short interest against a rising price is the clearest tension in the setup. Yet the borrow market tells a relaxed story — availability is running around 310%, meaning there are more than three shares available to lend for every one already borrowed, and cost to borrow is a negligible 0.49%. There is no squeeze pressure here. Options traders are equally unfazed: the put/call ratio of 0.70 is fractionally below its 20-day average of 0.78, a slight lean toward calls that reflects neither alarm nor conviction. The stock closed at $76.35, down roughly 30% year-to-date but up nearly 2% on the week — a stock that has bounced but remains deeply underwater for 2026 holders.
The analyst community is divided on how much of Ollie's trouble is cyclical versus structural. Bulls point to traffic trends they expect to reaccelerate into Q3, a valuation — around 15.8x trailing earnings — that sits near multi-year lows, and a closeout model that historically gains share when consumers trade down. Goldman Sachs and Piper Sandler both hold Buy-equivalent ratings, though Goldman trimmed its target twice in the past three months, most recently to $112 from $129 in late June. Wells Fargo maintained its Overweight this week but cut to $100 from $115. JP Morgan's move is the most pointed signal from the Street: Matthew Boss downgraded to Neutral in early July, slashing his target from $152 to $70 — a number the stock briefly threatened before bouncing — before nudging it back to $73 this week. Bears focus on weak comparable-store trends, margin pressure from gas prices and promotional intensity, and the difficulty of sourcing attractive closeout merchandise in the current inventory environment. The consensus target of $107 implies more than 40% upside from current levels, but that gap has been widening for months as targets have ratcheted lower rather than the stock recovering.
Institutional buying has been notable in the background. FMR added nearly 2 million shares through June, bringing its stake to 14.5% of shares outstanding. Wasatch, Capital Research, and T. Rowe Price each added more than a million shares in the same period. Against that accumulation, insider activity in the 90-day window is negligible — a COO award and a small tax-withholding sale totalling around $24,000, nothing that changes the read.
Tomorrow's print tests whether the Q2 traffic trends management has been signalling can survive contact with the numbers, and whether comparable-store sales are tracking toward the Q3 normalisation that bulls are pricing in — or whether the Street's target-cutting cycle has further to run.
See the live data behind this article on ORTEX.
Open OLLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
